NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
Estimated value
£192.0m
Awarded value
£192.0m
Awarded 15 Feb 2019
Suppliers
1
Lots
1
1 awarded
Published
25 Mar 2019
Deadline 11 Dec 2018
Description
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.
Scope
- Reference
- tender_192534/724684
- Total value
- £192,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Mar 2019 to 28 Feb 2021
- CPV classifications
- 33141530
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 11 Dec 2018, 12:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£192.0m
Award date
15 Feb 2019
Contract start
01 Mar 2019
Contract end
28 Feb 2021